Lithovius, Raija
,
Gordin, Daniel
Forsblom, Carol
Saraheimo, Markku
Harjutsalo, Valma
Groop, Per-Henrik
Article History
Received: 31 January 2018
Accepted: 23 April 2018
First Online: 24 May 2018
Duality of interest
: P-HG has received lecture honoraria from Astra Zeneca, Boehringer Ingelheim, Eli Lilly, EloWater, Genzyme, Medscape, MSD, Novartis, Novo Nordisk and Sanofi. P-HG is an advisory board member for AbbVie, Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Medscape, MSD, Novartis, Novo Nordisk and Sanofi. P-HG has received investigator-initiated grants from Eli Lilly and Roche. MS has received lecture fees from Astra Zeneca, BD, Eli Lilly, Infucare, Medtronic, Novo Nordisk, Roche and Sanofi-Aventis, and is an advisory board member of Medtronic in Scandinavia, Abbott Diabetes Care EMEA and the Insulin Advisory Board of Novo Nordisk Finland. The funding sources were not involved in the design or conduct of the study. All other authors declare that there is no duality of interest associated with this manuscript.